Avid Bioservices Reports Financial Results for First Quarter Fiscal 2020 and Recent Developments
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Avid Bioservices (CDMO) Misses Q4 EPS by 5c, Reaffirms Rev. Guidance
September 5, 2019 4:14 PM EDTAvid Bioservices (NASDAQ: CDMO) reported Q4 EPS of ($0.08), $0.05 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $15.3 million versus the consensus estimate of $14.36 million.
Reaffirms Fiscal 2020 Projected Revenue of $64 to $67 MillionFor earnings history and earnings-related data on Avid Bioservices (CDMO) click here.
... More